RNAi: Prokaryotes Get in on the Act

Slides:



Advertisements
Similar presentations
CRISPR Immunity Relies on the Consecutive Binding and Degradation of Negatively Supercoiled Invader DNA by Cascade and Cas3 Edze R. Westra, Paul B.G. van.
Advertisements

Regulatory RNAs. RNA DNA mRNA rRNA tRNA snRNA snoRNAmicroRNA siRNAribozymes Protein synthesis Splicing of mRNA Processing of rRNA Regulation of gene expression.
Figure 2 Dicer and RISC (RNA-induced silencing complex).
Presented By: Diana Marquez
Presented By: Diana Marquez
by Prarthana Mohanraju, Kira S
A CRISPR View of Cleavage
Expanding the Biologist’s Toolkit with CRISPR-Cas9
CRISPR-Cas Systems: Prokaryotes Upgrade to Adaptive Immunity
Volume 56, Issue 4, Pages (November 2014)
DNA Replication Reaches the Breaking Point
ChIP-Seq Data Reveal Nucleosome Architecture of Human Promoters
New Hope for a MicroRNA Therapy for Liver Cancer
RNA-Guided RNA Cleavage by a CRISPR RNA-Cas Protein Complex
The First High-Resolution DNA “Methylome”
Tumor Evolution: A Problem of Histocompatibility
Noncoding RNAs and Gene Silencing
Knocking out the Argonautes
Sherif Abou Elela, Haller Igel, Manuel Ares  Cell 
RNA Interference in Mammals: The Virus Strikes Back
RNA Interference in Mammals: The Virus Strikes Back
Rafael Kramann, Marcus J. Moeller  Kidney International 
Figure 2 Cas9 targeting using crRNA (CRISPR
The Interfaces of Genetic Conflict Are Hot Spots for Innovation
CRISPR-based adaptive and heritable immunity in prokaryotes
Volume 45, Issue 3, Pages (February 2012)
Calorie Restriction à Lamarck
Takuo Osawa, Hideko Inanaga, Chikara Sato, Tomoyuki Numata 
CRISPR CRISPRs (clustered regularly interspaced short palindromic repeats) are repetitive nucleotide sequences followed by a short spacer DNA segments.
Codon Clarity or Conundrum?
CRISPR-Cas Systems: Prokaryotes Upgrade to Adaptive Immunity
Addison V. Wright, James K. Nuñez, Jennifer A. Doudna  Cell 
Volume 45, Issue 3, Pages (February 2012)
Chromatin Proteins Do Double Duty
Figure 1 Adaptive immune system of bacteria and archaea
A Lexicon for Homeodomain-DNA Recognition
Eukaryotic Transcription Activation: Right on Target
Single-Stranded DNA Cleavage by Divergent CRISPR-Cas9 Enzymes
Joseph Bondy-Denomy, Alan R. Davidson  Trends in Microbiology 
Volume 50, Issue 3, Pages (May 2013)
Volume 164, Issue 1, Pages (January 2016)
Volume 19, Issue 2, Pages (February 2011)
Dipali G. Sashital, Blake Wiedenheft, Jennifer A. Doudna 
Volume 133, Issue 1, Pages (April 2008)
The Role of the RNAi Machinery in Heterochromatin Formation
Programmable RNA Cleavage and Recognition by a Natural CRISPR-Cas9 System from Neisseria meningitidis  Beth A. Rousseau, Zhonggang Hou, Max J. Gramelspacher,
The Ribosome Emerges from a Black Box
Ryan N. Jackson, Blake Wiedenheft  Molecular Cell 
Phytochromes: Where to Start?
The Evolution of Antiviral Defense Systems
Volume 134, Issue 4, Pages (August 2008)
Asymmetry in the Assembly of the RNAi Enzyme Complex
DNA Double-Strand Breaks Come into Focus
Sorting of Drosophila Small Silencing RNAs
Proteins Kinases: Chromatin-Associated Enzymes?
Modifications on Translation Initiation
Knocking down Disease with siRNAs
Volume 60, Issue 3, Pages (November 2015)
A CRISPR Approach to Gene Targeting
Regulatory RNAs in Bacteria
Nadja Heidrich, Jörg Vogel  Molecular Cell 
Structure of an RNA Silencing Complex of the CRISPR-Cas Immune System
Origins and Mechanisms of miRNAs and siRNAs
Viral Suppressors of RNA-Based Viral Immunity: Host Targets
ChIP-Seq Data Reveal Nucleosome Architecture of Human Promoters
Transcriptional Scaffolds for Heterochromatin Assembly
The Biology of CRISPR-Cas: Backward and Forward
Volume 163, Issue 4, (November 2015)
Volume 65, Issue 6, Pages (March 2017)
Presentation transcript:

RNAi: Prokaryotes Get in on the Act John van der Oost, Stan J.J. Brouns  Cell  Volume 139, Issue 5, Pages 863-865 (November 2009) DOI: 10.1016/j.cell.2009.11.018 Copyright © 2009 Elsevier Inc. Terms and Conditions

Figure 1 RNA-Based Immune Defense Both prokaryotes and eukaryotes have an RNA-based defense system mediated by the CRISPR/Cas system or the RISC/RNAi system, respectively. (Left) Shown is the CRISPR/Cas system of the archaeon Pyrococcus furiosus. This is composed of CRISPRs (short DNA repeats separated by short spacers) associated with the Cas6 protein and the Cmr complex. The CRISPR/Cas system binds to and cleaves complementary target RNAs (such as those of RNA viruses), leading to their degradation. Blue boxes indicate repeats in CRISPR sequences. The double arrow in the Cmr complex indicates that small CRISPR-derived RNAs or crRNAs are truncated at distinct sites, yielding the corresponding mature psiRNAs that guide the complex to the complementary target RNAs (Carte et al., 2008 and Hale et al., 2009). (Right) Shown is the eukaryotic RNAi defense system in which siRNAs in the RISC complex target complementary RNAs, leading to their degradation. There are two key proteins in this system: Dicer, which “dices” double-stranded RNAs into siRNAs, and Argonaute in the RISC complex where the binding of siRNAs to target RNAs takes place (Jinek and Doudna, 2009; Wang et al., 2009). Arrowheads indicate ribonuclease activity; broken lines indicate hydrolysis at a fixed position via a ruler mechanism. Cell 2009 139, 863-865DOI: (10.1016/j.cell.2009.11.018) Copyright © 2009 Elsevier Inc. Terms and Conditions